+
Chapter 42: Medications for Dementia Test Bank

Chapter 42: Medications for Dementia Test Bank

Rating:
Rating
(0)
Author: adele Ros
Description:

http://homework.plus/chapter-42-medications-for-dementia-test-bank/

Chapter 42: Medications for Dementia
Test Bank
MULTIPLE CHOICE
1.   A patient is identified as having stage 2 Alzheimer’s disease and elects to take donepezil (Aricept). The patient asks the primary care nurse practitioner (NP) how long the medication will be needed. The NP should tell the patient that donepezil must be taken:
a.

until symptoms improve.

b.

indefinitely because it is not curative.

c.

for 24 weeks, which is when cognitive function improves in most patients.

d.

until symptoms worsen, when a switch to memantine (Namenda) will be needed.

2.   A patient who has Alzheimer’s disease has been taking donepezil for 1 year. The patient’s spouse reports a worsening of symptoms. The primary care NP should consider:
a.

switching to ginkgo biloba.

b.

adding an antidepressant medication.

c.

changing to galantamine (Razadyne).

d.

adding memantine hydrochloride (Namenda).

3.   Early-stage Alzheimer’s disease is diagnosed in a patient, and the primary care NP recommends therapy with a ChE inhibitor. The patient asks why drug treatment is necessary because most functioning is intact. The NP should explain that medication may:
a.

delay progression of symptoms.

b.

produce temporary disease remission.

c.

prevent depressive effects of the disease.

d.

reduce the need for adjunct medications later on.

4.   A patient has a diagnosis of depression and Alzheimer’s disease with mild, intermittent symptoms. The primary care NP should prescribe a(n):
a.

antidepressant.

b.

ChE inhibitor.

c.

antidepressant and ginkgo biloba.

d.

antidepressant and a ChE inhibitor.

5.   A patient who has Alzheimer’s disease begins taking donepezil (Aricept). After 3 months of treatment, the patient does not show improvement of symptoms. The primary care NP should:
a.

switch to rivastigmine (Exelon).

b.

switch to galantamine (Razadyne).

c.

switch to memantine (Namenda).

d.

continue donepezil and reevaluate in 3 months.

6.   A patient is newly diagnosed with Alzheimer’s disease stage 6 on the Global Deterioration Scale. The primary care NP should prescribe:
a.

donepezil (Aricept).

b.

rivastigmine (Exelon).

c.

memantine (Namenda).

d.

galantamine (Razadyne).

7.   A patient has been taking donepezil (Aricept) for several months after being diagnosed with Alzheimer’s disease. The patient’s spouse brings the patient to the clinic and reports that the patient seems to be having visual hallucinations. The primary care NP should:
a.

increase the dose.

b.

decrease the dose.

c.

switch to memantine (Namenda).

d.

switch to galantamine (Razadyne).

8.   A patient who has Alzheimer’s disease is taking 10 mg of donepezil daily and reports difficulty sleeping. The primary care NP should recommend:
a.

decreasing the dose to 5 mg.

b.

increasing the dose to 15 mg.

c.

taking the drug in the morning.

d.

taking the drug in the evening.

9.   A patient who is diagnosed with Alzheimer’s disease experiences visual hallucinations. The primary care NP should initially prescribe:
a.

donepezil (Aricept).

b.

rivastigmine (Exelon).

c.

memantine (Namenda).

d.

galantamine (Razadyne). 


(more)
See More
Try a College Course Free

Sophia’s self-paced online courses are a great way to save time and money as you earn credits eligible for transfer to over 2,000 colleges and universities.*

Begin Free Trial
No credit card required

25 Sophia partners guarantee credit transfer.

221 Institutions have accepted or given pre-approval for credit transfer.

* The American Council on Education's College Credit Recommendation Service (ACE Credit®) has evaluated and recommended college credit for 20 of Sophia’s online courses. More than 2,000 colleges and universities consider ACE CREDIT recommendations in determining the applicability to their course and degree programs.

Tutorial